-
Lung Cancer: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Lung Cancer: Targets and Therapy
(155,002) Views
1179-2728
ISSN: 1179-2728
An international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Indexed online:
- Embase, Emcare and Scopus
- American Chemical Society's 'Chemical Abstracts Service'
- Directory of Open Access Journals (DOAJ)
- OAIster - The Open Access Initiative
- ResearchGATE scientific network
Article Processing Statistics:
21 From submission of manuscript to first editorial decision (including peer-review)
- American Thoracic Society Conference
Dove Press will exhibit at the American Thoracic Society National Conference in Philadelphia on May 17 - 22. We invite you to come and meet Dr. Richard E Russell, our Founding Editor, at Dove Medical Press Booth 1437 on May 20th at 2:00 PM.
- ASCO 2013 Meet the Editor
We invite you to meet Prof Dr Hans-Joachim Schmoll at the Dove Medical Press booth 22102 on June 1st at 11am. Prof Dr Schmoll is the Editor-in-Chief of the journal OncoTargets and Therapy (IF 1.26).
